Post Profile

Scientists Identify Protein Involved in Restoring Effectiveness of Common Treatment for Breast Cancer

Breast cancer is the most frequently diagnosed cancer among women, with estrogen-receptor-positive (ER+) being the most common type. Drugs used to treat this cancer, such as tamoxifen and Faslodex, block the hormone estrogen receptor that ER+ cancer cells need to grow. One problem with these treatments is that many tumors initially responsive to the drugs develop resistance, making the medicines less effective.
read more


Related Posts

Cold winters freezing out breast cancer treatment

Academics / General Science : ScienceDaily: Science Society

For women diagnosed with estrogen receptor positive breast cancer, tamoxifen is an essential drug used in treatment and prevention. Currently, tamoxifen is used in a one-size-fits-all approach where the same dose is prescribed for e...

Possible therapy for tamoxifen resistant breast cancer identified

Academics / General Science : Science Codex

The hormone estrogen stimulates the growth of breast cancers that are estrogen-receptor positive, the most common form of breast cancer. The drug tamoxifen blocks this estrogen effect and prolongs the lives of, and helps to cure, pa...

Musculoskeletal Side Effects From Breast Cancer Treatment Are Not Long Term

Health : Medical News Today

Around 75% of the 48,000 women annually diagnosed with breast cancer in the UK suffer from an estrogen receptor positive tumor, which implies the involvement of the hormone estrogen in cancer growth. Tamoxifen and exemestane are bot...

Seasonal Effect Revealed For Tamoxifen In Breast Cancer Treatment

Health : Medical News Today

For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer. Currently, tamoxifen is used i...

Researchers discover new hormone receptors to target when treating breast cancer

Health : Medical News Today

About three-quarters of breast cancers, the most common cancer in women in the U.S., are estrogen hormone dependent. Patients with this type of breast cancer are initially treated with drugs that block estrogen, such as Tamoxifen. H...


Copyright © 2016 Regator, LLC